fda approved semaglutide for weight loss New Medication Wegovy™ by the U.S. FDA | The FDA

If you are using or considering GLP-1s (or peptides for metabolic concerns, weight loss, or hormone optimization), you deserve to know the full picture

Durante este periodo, los investigadores encontraron aproximadamente un milln de nuevos usuarios de GLP-1RA y los clasificaron en funcin de si tenan diabetes, obesidad u otras afecciones relacionadas cuando se les recet el medicamento

W., Lambert, L

For those seeking holistic weight loss , recognizing the role of the gut-brain axis is crucial

Animal studies have demonstrated that these drugs can improve functional recovery after cerebral ischemia reperfusion by inhibiting inflammatory responses, reducing apoptosis, and promoting neurogenesis

Furthermore, studies such as the STEP-HFpEF trial with GLP-1 receptor agonists have shown optimized exercise capacity and reduced heart failure symptoms in patients